Cassidy, T., & Craig, M. (2019). Determinants of combination GM-CSF immunotherapy and oncolytic virotherapy success identified through in silico treatment personalization. PLoS Comput Biol.
Chicago Style aipamenaCassidy, Tyler, and Morgan Craig. "Determinants of Combination GM-CSF Immunotherapy and Oncolytic Virotherapy Success Identified Through in Silico Treatment Personalization." PLoS Comput Biol 2019.
MLA aipamenaCassidy, Tyler, and Morgan Craig. "Determinants of Combination GM-CSF Immunotherapy and Oncolytic Virotherapy Success Identified Through in Silico Treatment Personalization." PLoS Comput Biol 2019.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.